Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan Shares Drop After Alzheimer’s Drug Development Halted
Elan Shares Drop After Alzheimer’s Drug Development Halted
Elan Shares Drop After Alzheimer’s Drug Development Halted
Submitted by
admin
on August 7, 2012 - 11:44am
Source:
Bloomberg
News Tags:
Elan
Pfizer
JNJ
bapineuzumab
Alzheimer's disease
Headline:
Elan Shares Drop After Alzheimer’s Drug Development Halted
Do Not Allow Advertisers to Use My Personal information
